INVIVO THERAPEUTICS HOLDINGS CORP. Annual Operating Lease, Payments in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Invivo Therapeutics Holdings Corp. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2022.
  • Invivo Therapeutics Holdings Corp. Operating Lease, Payments for the quarter ending September 30, 2023 was $73K, a 31.1% decline year-over-year.
  • Invivo Therapeutics Holdings Corp. Operating Lease, Payments for the twelve months ending September 30, 2023 was $400K, a 5.88% decline year-over-year.
  • Invivo Therapeutics Holdings Corp. annual Operating Lease, Payments for 2022 was $427K, a 5.96% increase from 2021.
  • Invivo Therapeutics Holdings Corp. annual Operating Lease, Payments for 2021 was $403K, a 7.47% increase from 2020.
  • Invivo Therapeutics Holdings Corp. annual Operating Lease, Payments for 2020 was $375K, a 54.3% increase from 2019.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $427K +$24K +5.96% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-01
2021 $403K +$28K +7.47% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 $375K +$132K +54.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-07
2019 $243K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.